Bristol-Myers Squibb buy The Goldman Sachs Group, Inc.
Start price
30.10.23
/
50%
€48.25
Target price
30.10.24
€65.03
Performance (%)
-11.77%
Price
15:05
€41.47
Summary
This prediction is currently active. The prediction for Bristol-Myers Squibb disappoints with a performance of -11.77%. Dividends of €1.10 are taken into consideration when calculating the performance. This prediction currently runs until 30.10.24. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Bristol-Myers Squibb | -9.864% | -9.864% |
iShares Core DAX® | -0.992% | -3.231% |
iShares Nasdaq 100 | -0.225% | -3.339% |
iShares Nikkei 225® | -0.736% | -7.859% |
iShares S&P 500 | -0.509% | -2.979% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Bristol-Myers Squibb diskutieren
Bristol-Myers Squibb (NYSE: BMY) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $81.00 to $69.00. They now have a "buy" rating on the stock.
Ratings data for BMY provided by MarketBeat